How Much Does a Bone Marrow Transplant Cost?

Unfortunately there is no single answer to the question of how much a bone marrow transplant might cost. So many things factor into a bone marrow transplant, making the total actual cost of such a procedure—assuming the patient has no insurance—range from $80,000 up to $400,000. Complications such as graft versus host disease can make any procedure exceptionally more expensive, not to mention life-threatening.

Recent Cost Studies

The most recently published study relating to the cost of a bone marrow transplantation was carried out by researchers from both the Center for International Blood and Marrow Transplant Research and the National Marrow Donor Program.

These researchers—whose work was published in the journal Bone Marrow Transplant in the summer of 2012—examined an "administrative claims database representing a national, commercially insured population" in order to determine what the average costs are concerning both autologous and allogeneic transplantations.

Allogeneic transplantations more expensive

Since allogeneic transplantations are coming from another donor, they are understandably more expensive than autologous transplants, in which the patient banks and receives his or her own bone marrow or peripheral stem cells.

The patients they looked at had undergone a transplant between the years 2007 and 2009, and researchers only looked at the costs generated through the first 100 days post-transplantation, which suggests that they did not include any costs associated with the preparative regimen of high-dose chemotherapy and radiation, or the time in the hospital prior to the procedure.

Nonetheless, they determined that:

-- The median 100-day total costs for an autologous transplant was $99,899. Costs ranged from as low as $73,914 to a high of $140,555.

-- The median 100-day total costs for an allogeneic transplant was $203,026. Costs here ranged from a low of $141,742 to a high of $316,426.

They note that an overwhelming majority of costs occur during the initial transplant hospitalization and that costs tend to be higher among pediatric patients.

Source: Majhail NS et al. Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large National Private Claims Database. Bone Marrow Transplant. 2012 Jul 9. doi: 10.1038/bmt.2012.133.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap